日本新薬の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2017/12/25 | 8,310 | 8,480 | 8,310 | 8,410 | +140 | +1.7% | 127,000 |
| 2017/12/22 | 8,130 | 8,330 | 8,110 | 8,270 | +160 | +2% | 158,700 |
| 2017/12/21 | 8,060 | 8,130 | 8,040 | 8,110 | ±0 | ±0% | 147,800 |
| 2017/12/20 | 8,210 | 8,320 | 8,070 | 8,110 | -120 | -1.5% | 190,100 |
| 2017/12/19 | 8,380 | 8,380 | 8,220 | 8,230 | -150 | -1.8% | 97,100 |
| 2017/12/18 | 8,280 | 8,430 | 8,230 | 8,380 | +180 | +2.2% | 162,300 |
| 2017/12/15 | 8,180 | 8,240 | 8,150 | 8,200 | -20 | -0.2% | 134,800 |
| 2017/12/14 | 8,290 | 8,330 | 8,180 | 8,220 | -100 | -1.2% | 159,800 |
| 2017/12/13 | 8,140 | 8,370 | 8,140 | 8,320 | +250 | +3.1% | 301,500 |
| 2017/12/12 | 8,000 | 8,100 | 7,970 | 8,070 | +140 | +1.8% | 171,000 |
| 2017/12/11 | 7,880 | 7,950 | 7,770 | 7,930 | +110 | +1.4% | 138,700 |
| 2017/12/08 | 7,660 | 7,850 | 7,660 | 7,820 | +10 | +0.1% | 176,900 |
| 2017/12/07 | 7,690 | 7,870 | 7,680 | 7,810 | +180 | +2.4% | 149,500 |
| 2017/12/06 | 7,780 | 7,810 | 7,610 | 7,630 | -190 | -2.4% | 168,000 |
| 2017/12/05 | 7,850 | 7,850 | 7,790 | 7,820 | -100 | -1.3% | 211,800 |
| 2017/12/04 | 7,980 | 8,060 | 7,920 | 7,920 | -10 | -0.1% | 125,000 |
| 2017/12/01 | 8,010 | 8,030 | 7,900 | 7,930 | -110 | -1.4% | 135,400 |
| 2017/11/30 | 7,970 | 8,080 | 7,820 | 8,040 | +60 | +0.8% | 216,600 |
| 2017/11/29 | 8,020 | 8,060 | 7,940 | 7,980 | -80 | -1% | 165,800 |
| 2017/11/28 | 8,100 | 8,130 | 8,040 | 8,060 | +30 | +0.4% | 141,100 |
| 2017/11/27 | 8,040 | 8,060 | 7,970 | 8,030 | +100 | +1.3% | 149,200 |
| 2017/11/24 | 7,950 | 7,970 | 7,890 | 7,930 | -20 | -0.3% | 90,500 |
| 2017/11/22 | 7,980 | 8,020 | 7,950 | 7,950 | -60 | -0.7% | 152,200 |
| 2017/11/21 | 7,980 | 8,090 | 7,910 | 8,010 | -10 | -0.1% | 149,400 |
| 2017/11/20 | 7,840 | 8,050 | 7,830 | 8,020 | +150 | +1.9% | 233,600 |
| 2017/11/17 | 7,780 | 7,880 | 7,680 | 7,870 | +240 | +3.1% | 330,000 |
| 2017/11/16 | 7,370 | 7,650 | 7,360 | 7,630 | +220 | +3% | 196,900 |
| 2017/11/15 | 7,520 | 7,580 | 7,390 | 7,410 | -190 | -2.5% | 291,400 |
| 2017/11/14 | 7,760 | 7,830 | 7,580 | 7,600 | -180 | -2.3% | 345,100 |
| 2017/11/13 | 7,870 | 7,920 | 7,720 | 7,780 | -180 | -2.3% | 262,000 |
| 2017/11/10 | 7,700 | 7,990 | 7,700 | 7,960 | +150 | +1.9% | 385,300 |
| 2017/11/09 | 7,820 | 7,980 | 7,740 | 7,810 | +230 | +3% | 650,800 |
| 2017/11/08 | 7,760 | 7,770 | 7,540 | 7,580 | -160 | -2.1% | 322,700 |
| 2017/11/07 | 7,650 | 7,800 | 7,630 | 7,740 | -210 | -2.6% | 387,600 |
| 2017/11/06 | 8,060 | 8,090 | 7,930 | 7,950 | -20 | -0.3% | 216,300 |
| 2017/11/02 | 8,010 | 8,020 | 7,950 | 7,970 | -40 | -0.5% | 163,800 |
| 2017/11/01 | 8,030 | 8,060 | 7,970 | 8,010 | -10 | -0.1% | 299,600 |
| 2017/10/31 | 7,960 | 8,030 | 7,930 | 8,020 | +30 | +0.4% | 207,300 |
| 2017/10/30 | 8,030 | 8,080 | 7,930 | 7,990 | -130 | -1.6% | 563,000 |
| 2017/10/27 | 8,100 | 8,140 | 8,050 | 8,120 | +60 | +0.7% | 182,400 |
| 2017/10/26 | 8,130 | 8,150 | 8,050 | 8,060 | -40 | -0.5% | 185,200 |
| 2017/10/25 | 8,150 | 8,190 | 8,080 | 8,100 | -90 | -1.1% | 202,700 |
| 2017/10/24 | 8,100 | 8,200 | 8,060 | 8,190 | -10 | -0.1% | 276,500 |
| 2017/10/23 | 8,010 | 8,210 | 7,970 | 8,200 | +310 | +3.9% | 377,200 |
| 2017/10/20 | 7,780 | 7,920 | 7,770 | 7,890 | +150 | +1.9% | 315,900 |
| 2017/10/19 | 7,740 | 7,800 | 7,650 | 7,740 | ±0 | ±0% | 547,500 |
| 2017/10/18 | 7,770 | 7,770 | 7,670 | 7,740 | +10 | +0.1% | 268,300 |
| 2017/10/17 | 7,820 | 7,840 | 7,710 | 7,730 | -110 | -1.4% | 175,100 |
| 2017/10/16 | 7,910 | 7,940 | 7,800 | 7,840 | -90 | -1.1% | 189,200 |
| 2017/10/13 | 7,850 | 7,960 | 7,830 | 7,930 | +10 | +0.1% | 176,600 |
1851～
1900
件表示中 / 3749件
類似銘柄と比較する
現在ご覧いただいている「日本新薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 日本新薬 | 321,800円 | +8.0% | -15.3% | 3.85% | 9.03倍 | 0.88倍 |
|
医家向け医薬品主体、自社創薬は泌尿器科、血液内科、難病・希少疾患に集中。機能食品も育成 |
| 久光薬 | 400,500円 | +5.8% | +1.2% | 3.00% | 12.96倍 | 1.04倍 |
|
貼る鎮痛消炎剤首位。医療用シェア５割。大衆薬「サロンパス」で有名。米国、中国など海外強化 |
| ツムラ | 366,200円 | +3.8% | -19.9% | 3.71% | 11.90倍 | 0.91倍 |
|
医療用漢方薬で国内シェア８割超。高齢者、がん支持療法、女性関連の３領域を重点に市場深耕 |
| サワイＧＨＤ | 193,300円 | +5.9% | +684.6% | 2.85% | 12.83倍 | 1.28倍 |
|
ジェネリック（後発）薬大手メーカー。２１年春に沢井製薬が持株会社化。大型買収で米国本格展開 |
| ペプチド | 173,100円 | +5.0% | +1.5% | 0.00% | 14.80倍 | 3.94倍 |
|
東大発のペプチド創薬ベンチャーの雄。海外製薬大手との提携多数。買収で放射性医薬品に参入 |
市場注目の銘柄
チャート関連のコラム
